Evidence map›Paper›PMID 26553073›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid Arthritis.

Salah Mansour, Anna S Tocheva, Joseph P Sanderson, Lyndsey M Goulston, Helen Platten, Lina Serhal, Camille Parsons, Mark H Edwards, Christopher H Woelk, Paul T Elkington and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Salah MansourClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom; Stephan.gadola@novartis.com s.mansour@soton.ac.uk.
Anna S TochevaClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;
Joseph P SandersonAdaptimmune, Abingdon OX14 4RY, United Kingdom;
Lyndsey M GoulstonMedical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, United Kingdom; National Institute for Health Research Wellcome Trust Clinical Research Facility, University of Southampton, Southampton SO16 6YD, United Kingdom;
Helen PlattenNational Institute for Health Research Wellcome Trust Clinical Research Facility, University of Southampton, Southampton SO16 6YD, United Kingdom;
Lina SerhalNational Institute for Health Research Wellcome Trust Clinical Research Facility, University of Southampton, Southampton SO16 6YD, United Kingdom;
Camille ParsonsMedical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, United Kingdom;
Mark H EdwardsMedical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, United Kingdom; National Institute for Health Research Wellcome Trust Clinical Research Facility, University of Southampton, Southampton SO16 6YD, United Kingdom;
Christopher H WoelkClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom;
Paul T ElkingtonClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom; Institute for Life Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom;
Tim ElliottInstitute for Life Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom; Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;
Cyrus CooperMedical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, United Kingdom; National Institute for Health Research Wellcome Trust Clinical Research Facility, University of Southampton, Southampton SO16 6YD, United Kingdom; Oxford National Institute for Health Research Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7HE, United Kingdom; and.
Christopher J EdwardsMedical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, United Kingdom; National Institute for Health Research Wellcome Trust Clinical Research Facility, University of Southampton, Southampton SO16 6YD, United Kingdom; Oxford National Institute for Health Research Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7HE, United Kingdom; and.
Stephan D GadolaClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom; National Institute for Health Research Wellcome Trust Clinical Research Facility, University of Southampton, Southampton SO16 6YD, United Kingdom; Novartis Institutes of Biomedical Research, 4002 Basel, Switzerland Stephan.gadola@novartis.com s.mansour@soton.ac.uk.
University of Southampton · GBNational Institute for Health Research · GBAdaptimmune (United Kingdom) · GBMRC Lifecourse Epidemiology Unit · GBNIHR Wellcome Trust Southampton Clinical Research Facility · GBNovartis (Switzerland) · CH

Funding

Arthritis Research UK 18892Cancer Research UK 16997Medical Research Council MC_U147585819Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UU_12011/1
6 · The paper itself

Abstract

Invariant NKT cells (iNKT) are potent immunoregulatory T cells that recognize CD1d via a semi-invariant TCR (iNKT-TCR). Despite the knowledge of a defective iNKT pool in several autoimmune conditions, including rheumatoid arthritis (RA), a clear understanding of the intrinsic mechanisms, including qualitative and structural changes of the human iNKT repertoire at the earlier stages of autoimmune disease, is lacking. In this study, we compared the structure and function of the iNKT repertoire in early RA patients with age- and gender-matched controls. We analyzed the phenotype and function of the ex vivo iNKT repertoire as well as CD1d Ag presentation, combined with analyses of a large panel of ex vivo sorted iNKT clones. We show that circulating iNKTs were reduced in early RA, and their frequency was inversely correlated to disease activity score 28. Proliferative iNKT responses were defective in early RA, independent of CD1d function. Functional iNKT alterations were associated with a skewed iNKT-TCR repertoire with a selective reduction of high-affinity iNKT clones in early RA. Furthermore, high-affinity iNKTs in early RA exhibited an altered functional Th profile with Th1- or Th2-like phenotype, in treatment-naive and treated patients, respectively, compared with Th0-like Th profiles exhibited by high-affinity iNKTs in controls. To our knowledge, this is the first study to provide a mechanism for the intrinsic qualitative defects of the circulating iNKT clonal repertoire in early RA, demonstrating defects of iNKTs bearing high-affinity TCRs. These defects may contribute to immune dysregulation, and our findings could be exploited for future therapeutic intervention.

Indexed as

AdultAgedAged, 80 and overAntigens, CD1dArthritis, RheumatoidClonal DeletionClone CellsCross-Sectional StudiesCytokinesFemaleHumansMaleMiddle AgedNatural Killer T-CellsT-Cell Antigen Receptor SpecificityTh1-Th2 BalanceAntigens, CD1dCytokines

Identifiers

PMID26553073
PMCPMC4671310
OpenAlexW2136464107

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.